Outpatient antibiotic use in Dutch infants after 10-valent pneumococcal vaccine introduction: a time-series analysis

Alexandre C Fortanier1, Roderick P Venekamp1, Rebecca K Stellato1

  • 1Julius Center for Health Sciences and Primary Care, University Medical Center, Utrecht, The Netherlands.

BMJ Open
|July 2, 2018
PubMed

Insights

Switching from the 7-valent to the 10-valent pneumococcal conjugate vaccine (PCV) in Dutch infants modestly reduced outpatient antibiotic use. Geographical vaccination coverage did not significantly modify this association.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Public Health

Background:

  • The introduction of pneumococcal conjugate vaccines (PCVs) has significantly impacted childhood infectious diseases.
  • Understanding the effects of vaccine composition changes on antibiotic use is crucial for antimicrobial stewardship.

Purpose of the Study:

  • To evaluate the impact of switching from a 7-valent PCV (PCV7) to a 10-valent PCV (PCV10) on antibiotic consumption in Dutch infants.
  • To determine if geographical vaccination coverage influences the association between PCV switch and antibiotic use.

Main Methods:

  • A population-based cohort study utilizing anonymized antibiotic purchase data from 255,154 Dutch infants (aged <2 years) between 2006 and 2013.
  • Time-series analysis was employed to estimate changes in monthly antibiotic use before and after PCV10 introduction, accounting for seasonality and autocorrelation.
  • The study investigated potential interactions between vaccination coverage levels and the observed changes in antibiotic use.

Main Results:

  • The introduction of PCV10 was associated with a 1.6% overall reduction in infant antibiotic use (Purchase Rate Ratio: 0.98).
  • A significant shift in the trend of antibiotic use was observed post-PCV10 introduction, with a decrease in prescriptions compared to the PCV7 period.
  • No significant evidence was found that PCV vaccination coverage modified the association, though the study may have lacked power to detect such effects.

Conclusions:

  • The transition from PCV7 to PCV10 in the Netherlands was linked to a modest decrease in outpatient antibiotic consumption among infants.
  • Further research with enhanced statistical power may be needed to fully elucidate the role of vaccination coverage in this association.
Abstract

Related Concept Videos

Time-Series Graph00:54

Time-Series Graph

A time-series graph is a line graph with repeated measurements taken at successive intervals of time. It is also called a time series chart. To construct a time-series graph, one must look at both pieces of a paired data set. The horizontal axis is used to plot the time increments, and the vertical axis is used to plot the values of the variable that one is measuring. By using the axes in this way, each point on the graph will correspond to time and a measured quantity. The points on the graph...
5.2K
Vaccinations01:51

Vaccinations

Overview
51.8K
RLC Series Circuits: Introduction01:25

RLC Series Circuits: Introduction

Consider an RLC series circuit consisting of a resistor, an inductor, and a capacitor connected to an AC voltage source. A current, which varies sinusoidally over time, flows through the circuit, and this can be expressed by the following equation:
2.8K
Discrete-Time Fourier Series01:20

Discrete-Time Fourier Series

The Discrete-Time Fourier Series (DTFS) is a fundamental concept in signal processing, serving as the discrete-time counterpart to the continuous-time Fourier series. It allows for the representation and analysis of discrete-time periodic signals in terms of their frequency components. Unlike its continuous counterpart, which utilizes integrals, the calculation of DTFS expansion coefficients involves summations due to the discrete nature of the signal.
For a discrete-time periodic signal x[n]...
714
Antibiotic Selection00:57

Antibiotic Selection

Overview
60.0K
Introduction To Survival Analysis01:18

Introduction To Survival Analysis

Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
803